Anti-Cancer Effects of 3, 3’-Diindolylmethane on Human Hepatocellular Carcinoma Cells Is Enhanced by Calcium Ionophore: The Role of Cytosolic Ca2+ and p38 MAPK

Human liver regeneration following massive hepatic necrosis – two distinct patterns

(2019) Katalin Dezső et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway

(2019) Yu-Ru Lee et al.   SCIENCE

Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging

(2019) Nobuhiro Takahashi et al.   Cancers

The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer

(2018) Amir Tajbakhsh et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Hepatocellular carcinoma

(2018) Alejandro Forner et al.   LANCET

Tamoxifen inhibits the proliferation of non‑melanoma skin cancer cells by increasing intracellular calcium concentration

(2018) Go Hasegawa et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Carvacrol induces mitochondria-mediated apoptosis via disruption of calcium homeostasis in human choriocarcinoma cells

(2018) Whasun Lim et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma

(2018) Gao-Min Liu et al.   Cell Death & Disease

3,3′-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy

(2016) Yang Ye et al.   BIOCHEMICAL PHARMACOLOGY

3,3′-Diindolylmethane inhibits VEGF expression through the HIF-1α and NF-κB pathways in human retinal pigment epithelial cells under chemical hypoxic conditions

(2015) HONGZOO PARK et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling

(2015) Wen-Xue Li et al.   Oncotarget

Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling

(2015) Wen-Jing Lu et al.   Oncotarget

Cytoprotective action of the potassium channel opener NS1619 under conditions of disrupted calcium homeostasis

(2014) Ludwika Chmielewska et al.   Pharmacological Reports

Aconitine-induced Ca2+ overload causes arrhythmia and triggers apoptosis through p38 MAPK signaling pathway in rats

(2014) Gui-bo Sun et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance

(2014) Valentina Grossi   WORLD JOURNAL OF GASTROENTEROLOGY

Calcium influx pathways in breast cancer: opportunities for pharmacological intervention

(2013) I Azimi et al.   BRITISH JOURNAL OF PHARMACOLOGY

3,3′-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway

(2013) XIU JUAN LI et al.   ONCOLOGY REPORTS

p38α Negatively Regulates Survival and Malignant Selection of Transformed Bronchioalveolar Stem Cells

(2013) Edwige Voisset et al.   PLoS One

The dietary phytochemical 3,3′-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling

(2012) Jing-Ru Weng et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma

(2012) Shen-Nien Wang et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Anti-proliferative and pro-apoptotic effects of 3,3′-diindolylmethane in human cervical cancer cells

(2012) JUNYONG ZHU et al.   ONCOLOGY REPORTS

Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update

(2012) John M. Kyriakis et al.   PHYSIOLOGICAL REVIEWS

3,3′-Diindolylmethane Induces G1 Arrest and Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia Cells

(2012) Lyndsey E. Shorey et al.   PLoS One

3,3′-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells

(2012) Laura M. Beaver et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Effect of diindolylmethane on Ca2+ movement and viability in HA59T human hepatoma cells

(2011) Jin-Shiung Cheng et al.   ARCHIVES OF TOXICOLOGY

Targeting the MAPK pathway in melanoma: Why some approaches succeed and other fail

(2010) Gajanan S. Inamdar et al.   BIOCHEMICAL PHARMACOLOGY

The Cytoprotective Action of the Potassium Channel Opener BMS-191095 in C2C12 Myoblasts is Related to the Modulation of Calcium Homeostasis

(2010) Dominika Malinska et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

3,3′-Diindolylmethane induces a G1 arrest in human prostate cancer cells irrespective of androgen receptor and p53 status

(2009) Omar I. Vivar et al.   BIOCHEMICAL PHARMACOLOGY

Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells

(2009) D D Meira et al.   BRITISH JOURNAL OF CANCER

3,3'-Diindolylmethane Induction of p75NTR-Dependent Cell Death via the p38 Mitogen-Activated Protein Kinase Pathway in Prostate Cancer Cells

(2009) F. S. Khwaja et al.   Cancer Prevention Research